@sholzberg@tsengeric Thanks for your always wonderful mentorship on this project Michelle! It was a great experience to work on an organic question that emerged from our clinic discussions.
Lewis et al
Big data 1L #DLBCL HDMTX CNS prophylaxis you have been waiting for!
CNS IPI 4-6 (>90%) or high risk feature
N=2300
HDMTX or nil
Well balanced
No diff in CNS relapse in any subgp
Massive global effort
Congrats to all involved
Esp @Dr_KatLewis + @chanyooncheah#ASH2021
Horwitz et al: Longer term FU of ECHELON-2.
Absolutely no difference in non-ALCL subtypes for CHP-BV compared with CHOP. In fact - could you argue CHOP is better in AITL.......?
(NB: CHP-BV is GREAT in ALCL though. Please use it!)
#ASH21#lymsm
@Sunnybrook@UofT_DoM Fan club in full force watching the inspiring Rena Buckstein convince the crowd at #ASH19 of the importance of considering frailty/vulnerability in the management of MDS.